v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 75,414 $ 59,129
Cost of revenue 32,587 25,850
Gross profit 42,827 33,279
Operating expenses    
Selling, general and administrative 34,792 28,425
Research and development 579 797
Stock-based compensation 2,451 2,311
Depreciation and amortization 388 348
Loss (gain) on disposal of property and equipment 356 (2,368)
Other income, net (35) (75)
Income from operations 4,296 3,841
Non-operating income and expenses    
Interest expense, net 305 179
Net income before taxes 3,991 3,662
Provision for income taxes 1,278 952
Net income 2,713 2,710
Net income attributable to noncontrolling interest 131 85
Net income attributable to Viemed Healthcare, Inc. $ 2,582 $ 2,625
Net income per share    
Basic (in dollars per share) $ 0.07 $ 0.07
Diluted (in dollars per share) $ 0.06 $ 0.06
Weighted average number of common shares outstanding:    
Basic (in shares) 38,428,588 39,426,753
Diluted (in shares) 40,491,298 41,627,876